Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Rodríguez-Vicente AE"'
Autor:
Pérez Carretero C; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., González T; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Quijada Álamo M; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Rigolin GM; Hematology Section, St. Anna University Hospital, Ferrara, Italy., Dubuc A; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Villaverde Ramiro Á; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Rodríguez-Sánchez A; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Rubio A; Department of Hematology, Hospital Miguel Servet, Zaragoza, Spain., Dávila J; Department of Hematology, Hospital Nuestra Señora de Sonsoles, Ávila, Spain., Vidal MJ; Department of Hematology, Hospital Universitario, León, Spain., González Gascón Y Marín I; Department of Hematology, Hospital Universitario Infanta Leonor. Universidad Complutense, Madrid, Spain., Hernández-Rivas JÁ; Department of Hematology, Hospital Universitario Infanta Leonor. Universidad Complutense, Madrid, Spain., Benito R; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Volpe V; Dana Farber Cancer Institute, Boston, Massachusetts, USA., Davids MS; Dana Farber Cancer Institute, Boston, Massachusetts, USA., Abramson JS; Massachusetts General Hospital, Boston, Massachusetts, USA., Cuneo A; Hematology Section, St. Anna University Hospital, Ferrara, Italy., Dal Cin P; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Rodríguez-Vicente AE; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain.; Department of Human Anatomy and Histology, Faculty of Medicine, University of Salamanca, Salamanca, Spain., Hernández-Rivas JM; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain.
Publikováno v:
American journal of hematology [Am J Hematol] 2024 Sep; Vol. 99 (9), pp. 1845-1848. Date of Electronic Publication: 2024 Jul 01.
Autor:
Muñoz-Novas C; Servicio de Hematología, Hospital Universitario Infanta Leonor, Madrid, Spain., González-Gascón-Y-Marín I; Servicio de Hematología, Hospital Universitario Infanta Leonor, Madrid, Spain., Figueroa I; Departamento de Medicina, Universidad Complutense, Madrid, Spain., Sánchez-Paz L; Servicio de Hematología, Hospital Universitario Infanta Leonor, Madrid, Spain., Pérez-Carretero C; IBSAL, IBMCC, Centro de Investigación del Cáncer, Servicio de Hematología, Hospital Universitario de Salamanca, Universidad de Salamanca-CSIC, Salamanca, Spain., Quijada-Álamo M; IBSAL, IBMCC, Centro de Investigación del Cáncer, Servicio de Hematología, Hospital Universitario de Salamanca, Universidad de Salamanca-CSIC, Salamanca, Spain., Rodríguez-Vicente AE; IBSAL, IBMCC, Centro de Investigación del Cáncer, Servicio de Hematología, Hospital Universitario de Salamanca, Universidad de Salamanca-CSIC, Salamanca, Spain., Infante MS; Servicio de Hematología, Hospital Universitario Infanta Leonor, Madrid, Spain., Foncillas MÁ; Servicio de Hematología, Hospital Universitario Infanta Leonor, Madrid, Spain., Landete E; Servicio de Hematología, Hospital Universitario Infanta Leonor, Madrid, Spain., Churruca J; Servicio de Hematología, Hospital Universitario Infanta Leonor, Madrid, Spain., Marín K; Servicio de Hematología, Hospital Universitario Infanta Leonor, Madrid, Spain., Ramos V; Servicio de Hematología, Hospital Universitario Infanta Leonor, Madrid, Spain., Sánchez Salto A; Servicio de Hematología, Hospital Universitario Infanta Leonor, Madrid, Spain., Hernández-Rivas JÁ; Servicio de Hematología, Hospital Universitario Infanta Leonor, Madrid, Spain.; Departamento de Medicina, Universidad Complutense, Madrid, Spain.
Publikováno v:
Global medical genetics [Glob Med Genet] 2024 Feb 12; Vol. 11 (1), pp. 59-68. Date of Electronic Publication: 2024 Feb 12 (Print Publication: 2024).
Autor:
González-Gascón-Y-Marín I; Department of Hematology, University Hospital Infanta Leonor, 28031 Madrid, Spain., Ballesteros-Andrés M; Department of Hematology, University General Hospital Gregorio Marañón, 28009 Madrid, Spain., Martínez-Flores S; Department of Geriatric Medicine, University Hospital Infanta Leonor, 28031 Madrid, Spain., Rodríguez-Vicente AE; IBSAL, IBMCC, CSIC, Cancer Research Center, University of Salamanca, 37007 Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, 37007 Salamanca, Spain., Pérez-Carretero C; IBSAL, IBMCC, CSIC, Cancer Research Center, University of Salamanca, 37007 Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, 37007 Salamanca, Spain., Quijada-Álamo M; IBSAL, IBMCC, CSIC, Cancer Research Center, University of Salamanca, 37007 Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, 37007 Salamanca, Spain., Rodríguez-Sánchez A; IBSAL, IBMCC, CSIC, Cancer Research Center, University of Salamanca, 37007 Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, 37007 Salamanca, Spain., Hernández-Rivas JÁ; Department of Hematology, University Hospital Infanta Leonor, 28031 Madrid, Spain.; Department of Medicine, Complutense University, 28040 Madrid, Spain.
Publikováno v:
Cancers [Cancers (Basel)] 2023 Sep 02; Vol. 15 (17). Date of Electronic Publication: 2023 Sep 02.
Autor:
Mansouri L; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Thorvaldsdottir B; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Sutton LA; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Karakatsoulis G; Centre for Research and Technology Hellas, Institute of Applied Biosciences, Thessaloniki, Greece.; Department of Mathematics, University of Ioannina, Ioannina, Greece., Meggendorfer M; MLL Munich Leukemia Laboratory, Munich, Germany., Parker H; Cancer Genomics, School for Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK., Nadeu F; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Brieghel C; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Laidou S; Centre for Research and Technology Hellas, Institute of Applied Biosciences, Thessaloniki, Greece., Moia R; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy., Rossi D; Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.; Laboratory of Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland., Catherwood M; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK., Kotaskova J; Department of Internal Medicine-Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.; Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Delgado J; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Hospital Clínic of Barcelona, Barcelona, Spain.; Universitat de Barcelona, Barcelona, Spain., Rodríguez-Vicente AE; Cancer Research Center (IBMCC) CSIC-University of Salamanca, Salamanca, Spain.; Instituto de Investigación Biomédica (IBSAL), Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Benito R; Cancer Research Center (IBMCC) CSIC-University of Salamanca, Salamanca, Spain.; Instituto de Investigación Biomédica (IBSAL), Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Rigolin GM; Hematology-Department of Medical Sciences, University of Ferrara, Ferrara, Italy., Bonfiglio S; Università Vita Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy., Scarfo L; Università Vita Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy., Mattsson M; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Davis Z; Molecular Pathology Department, University Hospitals Dorset, Bournemouth, UK., Gogia A; All India Institute of Medical Sciences (AIIMS), New Delhi, India., Rani L; All India Institute of Medical Sciences (AIIMS), New Delhi, India., Baliakas P; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Foroughi-Asl H; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Jylhä C; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Skaftason A; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Rapado I; Hospital Universitario 12 Octubre, Madrid, Spain.; Spanish National Cancer Research (CNIO), Madrid, Spain., Miras F; Hospital Universitario 12 Octubre, Madrid, Spain., Martinez-Lopez J; Hospital Universitario 12 Octubre, Madrid, Spain.; Spanish National Cancer Research (CNIO), Madrid, Spain., de la Serna J; Hospital Universitario 12 Octubre, Madrid, Spain.; Spanish National Cancer Research (CNIO), Madrid, Spain., Rivas JMH; Cancer Research Center (IBMCC) CSIC-University of Salamanca, Salamanca, Spain.; Instituto de Investigación Biomédica (IBSAL), Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Thornton P; Haematology Department, Beaumont Hospital, Dublin, Ireland., Larráyoz MJ; Hematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain., Calasanz MJ; Hematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain., Fésüs V; HCEMM-SE Molecular Oncohematology Research Group, Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary., Mátrai Z; Central Hospital of Southern Pest-National Institute of Hematology and Infectious Diseases, Budapest, Hungary., Bödör C; HCEMM-SE Molecular Oncohematology Research Group, Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary., Smedby KE; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden., Espinet B; Molecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar and Translational Research on Hematological Neoplasms Group, Hospital del Mar Research Institute (IMIM), Barcelona, Spain., Puiggros A; Molecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar and Translational Research on Hematological Neoplasms Group, Hospital del Mar Research Institute (IMIM), Barcelona, Spain., Gupta R; All India Institute of Medical Sciences (AIIMS), New Delhi, India., Bullinger L; Department of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany., Bosch F; Department of Hematology, Hospital Universitari Vall d'Hebron (HUVH), Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain., Tazón-Vega B; Department of Hematology, Hospital Universitari Vall d'Hebron (HUVH), Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain., Baran-Marszak F; Service d'hématologie Biologique Hôpital Avicenne Assistance Publique des Hôpitaux de Paris, Bobigny, France., Oscier D; Molecular Pathology Department, University Hospitals Dorset, Bournemouth, UK., Nguyen-Khac F; Sorbonne Université, Service d'Hématologie Clinique, Hôpital Pitié-Salpêtrière, APHP, Paris, France., Zenz T; Department of Oncology and Haematology, University Hospital and University of Zurich, Zurich, Switzerland., Terol MJ; Department of Hematology, INCLIVA Research Insitute, University of Valencia, Valencia, Spain., Cuneo A; Hematology-Department of Medical Sciences, University of Ferrara, Ferrara, Italy., Hernández-Sánchez M; Cancer Research Center (IBMCC) CSIC-University of Salamanca, Salamanca, Spain.; Instituto de Investigación Biomédica (IBSAL), Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Pospisilova S; Department of Internal Medicine-Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.; Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Mills K; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK., Gaidano G; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy., Niemann CU; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Campo E; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Hospital Clínic of Barcelona, Barcelona, Spain.; Universitat de Barcelona, Barcelona, Spain., Strefford JC; Cancer Genomics, School for Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK., Ghia P; Università Vita Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy., Stamatopoulos K; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Centre for Research and Technology Hellas, Institute of Applied Biosciences, Thessaloniki, Greece., Rosenquist R; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. richard.rosenquist@ki.se.; Clinical Genetics, Karolinska University Hospital, Solna, Sweden. richard.rosenquist@ki.se.
Publikováno v:
Leukemia [Leukemia] 2023 Feb; Vol. 37 (2), pp. 504.
Autor:
Mansouri L; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Thorvaldsdottir B; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Sutton LA; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Karakatsoulis G; Centre for Research and Technology Hellas, Institute of Applied Biosciences, Thessaloniki, Greece.; Department of Mathematics, University of Ioannina, Ioannina, Greece., Meggendorfer M; MLL Munich Leukemia Laboratory, Munich, Germany., Parker H; Cancer Genomics, School for Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK., Nadeu F; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Brieghel C; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Laidou S; Centre for Research and Technology Hellas, Institute of Applied Biosciences, Thessaloniki, Greece., Moia R; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy., Rossi D; Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.; Laboratory of Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland., Catherwood M; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK., Kotaskova J; Department of Internal Medicine-Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.; Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Delgado J; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Hospital Clínic of Barcelona, Barcelona, Spain.; Universitat de Barcelona, Barcelona, Spain., Rodríguez-Vicente AE; Cancer Research Center (IBMCC) CSIC-University of Salamanca, Salamanca, Spain.; Instituto de Investigación Biomédica (IBSAL), Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Benito R; Cancer Research Center (IBMCC) CSIC-University of Salamanca, Salamanca, Spain.; Instituto de Investigación Biomédica (IBSAL), Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Rigolin GM; Hematology-Department of Medical Sciences, University of Ferrara, Ferrara, Italy., Bonfiglio S; Università Vita Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy., Scarfo L; Università Vita Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy., Mattsson M; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Davis Z; Molecular Pathology Department, University Hospitals Dorset, Bournemouth, UK., Gogia A; All India Institute of Medical Sciences (AIIMS), New Delhi, India., Rani L; All India Institute of Medical Sciences (AIIMS), New Delhi, India., Baliakas P; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Foroughi-Asl H; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Jylhä C; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Skaftason A; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Rapado I; Hospital Universitario 12 Octubre, Madrid, Spain.; Spanish National Cancer Research (CNIO), Madrid, Spain., Miras F; Hospital Universitario 12 Octubre, Madrid, Spain., Martinez-Lopez J; Hospital Universitario 12 Octubre, Madrid, Spain.; Spanish National Cancer Research (CNIO), Madrid, Spain., de la Serna J; Hospital Universitario 12 Octubre, Madrid, Spain.; Spanish National Cancer Research (CNIO), Madrid, Spain., Rivas JMH; Cancer Research Center (IBMCC) CSIC-University of Salamanca, Salamanca, Spain.; Instituto de Investigación Biomédica (IBSAL), Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Thornton P; Haematology Department, Beaumont Hospital, Dublin, Ireland., Larráyoz MJ; Hematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain., Calasanz MJ; Hematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain., Fésüs V; HCEMM-SE Molecular Oncohematology Research Group, Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary., Mátrai Z; Central Hospital of Southern Pest-National Institute of Hematology and Infectious Diseases, Budapest, Hungary., Bödör C; HCEMM-SE Molecular Oncohematology Research Group, Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary., Smedby KE; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden., Espinet B; Molecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar and Translational Research on Hematological Neoplasms Group, Hospital del Mar Research Institute (IMIM), Barcelona, Spain., Puiggros A; Molecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar and Translational Research on Hematological Neoplasms Group, Hospital del Mar Research Institute (IMIM), Barcelona, Spain., Gupta R; All India Institute of Medical Sciences (AIIMS), New Delhi, India., Bullinger L; Department of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany., Bosch F; Department of Hematology, Hospital Universitari Vall d'Hebron (HUVH), Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain., Tazón-Vega B; Department of Hematology, Hospital Universitari Vall d'Hebron (HUVH), Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain., Baran-Marszak F; Service d'hématologie Biologique Hôpital Avicenne Assistance Publique des Hôpitaux de Paris, Bobigny, France., Oscier D; Molecular Pathology Department, University Hospitals Dorset, Bournemouth, UK., Nguyen-Khac F; Sorbonne Université, Service d'Hématologie Clinique, Hôpital Pitié-Salpêtrière, APHP, Paris, France., Zenz T; Department of Oncology and Haematology, University Hospital and University of Zurich, Zurich, Switzerland., Terol MJ; Department of Hematology, INCLIVA Research Insitute, University of Valencia, Valencia, Spain., Cuneo A; Hematology-Department of Medical Sciences, University of Ferrara, Ferrara, Italy., Hernández-Sánchez M; Cancer Research Center (IBMCC) CSIC-University of Salamanca, Salamanca, Spain.; Instituto de Investigación Biomédica (IBSAL), Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Pospisilova S; Department of Internal Medicine-Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.; Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Mills K; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK., Gaidano G; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy., Niemann CU; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Campo E; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Hospital Clínic of Barcelona, Barcelona, Spain.; Universitat de Barcelona, Barcelona, Spain., Strefford JC; Cancer Genomics, School for Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK., Ghia P; Università Vita Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy., Stamatopoulos K; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Centre for Research and Technology Hellas, Institute of Applied Biosciences, Thessaloniki, Greece., Rosenquist R; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. richard.rosenquist@ki.se.; Clinical Genetics, Karolinska University Hospital, Solna, Sweden. richard.rosenquist@ki.se.
Publikováno v:
Leukemia [Leukemia] 2023 Feb; Vol. 37 (2), pp. 339-347. Date of Electronic Publication: 2022 Dec 24.
Autor:
Cerisoli F; European Hematology Association, The Hague, The Netherlands., Ali F; Patient Health Impact, Pfizer, Montreal, Quebec, Canada., Bereczky T; Patvocates GmbH, Munich, Bayern, Germany., Bolaños N; Regional Management Europe, Lymphoma Coalition, Madrid, Spain., Bullinger L; Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt, Berlin, Germany., Dhanasiri S; Global Medical Affairs, Celgene International - A Bristol Myers Squibb Company, Boudry, Switzerland., Gallagher J; Pfizer Inc, New York, NY, USA., Pérez SG; Department of Medicines for Human Use, Spanish Agency of Medicines and Medical Devices (AEMPS), Madrid, Spain., Geissler J; Patvocates GmbH, Munich, Bayern, Germany., Guillevic Y; Global Medical Affairs, Celgene International - A Bristol Myers Squibb Company, Boudry, Switzerland., Harrison K; Science Policy and Research Programme, National Institute for Health and Care Excellence (NICE), Manchester, England, UK., Naoum A; European Hematology Association, The Hague, The Netherlands., Portulano C; Menarini Ricerche SpA, Florence, Italy., Rodríguez Vicente AE; Departamento de Medicina, Universidad de Salamanca, Salamanca, Spain., Schulze-Rath R; Medical Affairs & Pharmacovigilance, Pharmaceuticals, Bayer AG, Berlin, Germany., Gómez GY; Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), Madrid, Spain., Sanz G; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain; Hospital Universitari i Politècnic la Fe, Valencia, Spain., Hernández Rivas JM; Servicio de Hematología, Instituto de Investigación Biomédica de Salamanca (IBSAL), Departamento de Medicina, Hospital Universitario de Salamanca, Universidad de Salamanca, Salamanca, Spain. Electronic address: jmhr@usal.es.
Publikováno v:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2022 Oct; Vol. 25 (10), pp. 1760-1767. Date of Electronic Publication: 2022 May 18.
Autor:
Pérez-Carretero C; Universidad de Salamanca, IBSAL, IBMCC- Centro de Investigación del Cáncer (USAL-CSIC), Salamanca, Spain.; Servicio de Hematología, Hospital Universitario de Salamanca, Salamanca, Spain., Hernández-Sánchez M; Universidad de Salamanca, IBSAL, IBMCC- Centro de Investigación del Cáncer (USAL-CSIC), Salamanca, Spain.; Servicio de Hematología, Hospital Universitario de Salamanca, Salamanca, Spain., González T; Universidad de Salamanca, IBSAL, IBMCC- Centro de Investigación del Cáncer (USAL-CSIC), Salamanca, Spain.; Servicio de Hematología, Hospital Universitario de Salamanca, Salamanca, Spain., Quijada-Álamo M; Universidad de Salamanca, IBSAL, IBMCC- Centro de Investigación del Cáncer (USAL-CSIC), Salamanca, Spain.; Servicio de Hematología, Hospital Universitario de Salamanca, Salamanca, Spain., Martín-Izquierdo M; Universidad de Salamanca, IBSAL, IBMCC- Centro de Investigación del Cáncer (USAL-CSIC), Salamanca, Spain.; Servicio de Hematología, Hospital Universitario de Salamanca, Salamanca, Spain., Santos-Mínguez S; Universidad de Salamanca, IBSAL, IBMCC- Centro de Investigación del Cáncer (USAL-CSIC), Salamanca, Spain.; Servicio de Hematología, Hospital Universitario de Salamanca, Salamanca, Spain., Miguel-García C; Universidad de Salamanca, IBSAL, IBMCC- Centro de Investigación del Cáncer (USAL-CSIC), Salamanca, Spain.; Servicio de Hematología, Hospital Universitario de Salamanca, Salamanca, Spain., Vidal MJ; Servicio de Hematología, Hospital Universitario, León, Spain., García-De-Coca A; Servicio de Hematología, Hospital Clínico, Valladolid, Spain., Galende J; Servicio de Hematología, Hospital El Bierzo, Ponferrada, Spain., Pardal E; Servicio de Hematología, Hospital Virgen del Puerto, Plasencia, Spain., Aguilar C; Servicio de Hematología, Complejo Hospitalario de Soria, Soria, Spain., Vargas-Pabón M; Servicio de Hematología, Hospital Jarrio, Asturias, Spain., Dávila J; Servicio de Hematología, Hospital Nuestra Señora de Sonsoles, Ávila, Spain., Gascón-Y-Marín I; Servicio de Hematología, Hospital Universitario Infanta Leonor, Universidad Complutense, Madrid, Spain., Hernández-Rivas JÁ; Servicio de Hematología, Hospital Universitario Infanta Leonor, Universidad Complutense, Madrid, Spain., Benito R; Universidad de Salamanca, IBSAL, IBMCC- Centro de Investigación del Cáncer (USAL-CSIC), Salamanca, Spain.; Servicio de Hematología, Hospital Universitario de Salamanca, Salamanca, Spain., Hernández-Rivas JM; Universidad de Salamanca, IBSAL, IBMCC- Centro de Investigación del Cáncer (USAL-CSIC), Salamanca, Spain.; Servicio de Hematología, Hospital Universitario de Salamanca, Salamanca, Spain., Rodríguez-Vicente AE; Universidad de Salamanca, IBSAL, IBMCC- Centro de Investigación del Cáncer (USAL-CSIC), Salamanca, Spain.; Servicio de Hematología, Hospital Universitario de Salamanca, Salamanca, Spain.
Publikováno v:
American journal of hematology [Am J Hematol] 2022 Jul; Vol. 97 (7), pp. 903-914. Date of Electronic Publication: 2022 May 09.
Autor:
Quijada-Álamo M; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Hernández-Sánchez M; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, 02142, USA., Rodríguez-Vicente AE; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Pérez-Carretero C; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Rodríguez-Sánchez A; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Martín-Izquierdo M; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Alonso-Pérez V; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., García-Tuñón I; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Bastida JM; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Vidal-Manceñido MJ; Department of Hematology, Hospital Virgen Blanca, León, Spain., Galende J; Department of Hematology, Hospital del Bierzo, Ponferrada, Spain., Aguilar C; Department of Hematology, Hospital Santa Bárbara, Soria, Spain., Queizán JA; Department of Hematology, Hospital General de Segovia, Segovia, Spain., González-Gascón Y Marín I; Department of Hematology, Hospital Universitario Infanta Leonor. Universidad Complutense, Madrid, Spain., Hernández-Rivas JÁ; Department of Hematology, Hospital Universitario Infanta Leonor. Universidad Complutense, Madrid, Spain., Benito R; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Ordóñez JL; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain., Hernández-Rivas JM; University of Salamanca, IBSAL, IBMCC, CSIC, Cancer Research Center, Salamanca, Spain. jmhr@usal.es.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain. jmhr@usal.es.; Department of Medicine, University of Salamanca, Salamanca, Spain. jmhr@usal.es.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2021 Jul 09; Vol. 11 (7), pp. 127. Date of Electronic Publication: 2021 Jul 09.
Autor:
Pérez-Carretero C; Cancer Research Center (IBMCC) CSIC-University of Salamanca, 37007 Salamanca, Spain.; Instituto de Investigación Biomédica (IBSAL), 37007 Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, 37007 Salamanca, Spain., González-Gascón-Y-Marín I; Department of Hematology, Infanta Leonor University Hospital, 28031 Madrid, Spain., Rodríguez-Vicente AE; Cancer Research Center (IBMCC) CSIC-University of Salamanca, 37007 Salamanca, Spain.; Instituto de Investigación Biomédica (IBSAL), 37007 Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, 37007 Salamanca, Spain., Quijada-Álamo M; Cancer Research Center (IBMCC) CSIC-University of Salamanca, 37007 Salamanca, Spain.; Instituto de Investigación Biomédica (IBSAL), 37007 Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, 37007 Salamanca, Spain., Hernández-Rivas JÁ; Department of Hematology, Infanta Leonor University Hospital, 28031 Madrid, Spain.; Department of Medicine, Complutense University, 28040 Madrid, Spain., Hernández-Sánchez M; Cancer Research Center (IBMCC) CSIC-University of Salamanca, 37007 Salamanca, Spain.; Instituto de Investigación Biomédica (IBSAL), 37007 Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, 37007 Salamanca, Spain., Hernández-Rivas JM; Cancer Research Center (IBMCC) CSIC-University of Salamanca, 37007 Salamanca, Spain.; Instituto de Investigación Biomédica (IBSAL), 37007 Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, 37007 Salamanca, Spain.; Department of Medicine, University of Salamanca, 37008 Salamanca, Spain.
Publikováno v:
Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2021 May 10; Vol. 11 (5). Date of Electronic Publication: 2021 May 10.
Autor:
González-Gascón-Y-Marín I; Department of Hematology, Hospital Universitario Infanta Leonor, 28031 Madrid, Spain., Muñoz-Novas C; Department of Hematology, Hospital Universitario Infanta Leonor, 28031 Madrid, Spain., Rodríguez-Vicente AE; Centro de Investigación del Cáncer, Department of Hematology, Hospital Universitario de Salamanca, Salamanca-CSIC University, IBSAL, IBMCC, 37007 Salamanca, Spain., Quijada-Álamo M; Centro de Investigación del Cáncer, Department of Hematology, Hospital Universitario de Salamanca, Salamanca-CSIC University, IBSAL, IBMCC, 37007 Salamanca, Spain., Hernández-Sánchez M; Centro de Investigación del Cáncer, Department of Hematology, Hospital Universitario de Salamanca, Salamanca-CSIC University, IBSAL, IBMCC, 37007 Salamanca, Spain., Pérez-Carretero C; Centro de Investigación del Cáncer, Department of Hematology, Hospital Universitario de Salamanca, Salamanca-CSIC University, IBSAL, IBMCC, 37007 Salamanca, Spain., Ramos-Ascanio V; Department of Hematology, Hospital Universitario Infanta Leonor, 28031 Madrid, Spain., Hernández-Rivas JÁ; Department of Hematology, Hospital Universitario Infanta Leonor, 28031 Madrid, Spain.; Facultad de Medicina, Universidad Complutense de Madrid, 28040 Madrid, Spain.
Publikováno v:
Cancers [Cancers (Basel)] 2021 Apr 08; Vol. 13 (8). Date of Electronic Publication: 2021 Apr 08.